Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin - Archive ouverte HAL Access content directly
Journal Articles Travel Medicine and Infectious Disease Year : 2021

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin

Dates and versions

hal-03211439 , version 1 (28-04-2021)

Identifiers

Cite

Matthieu Million, Audrey Giraud-Gatineau, Jean-Christophe Lagier, Philippe Parola, Philippe Gautret, et al.. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Medicine and Infectious Disease, 2021, 39, pp.101954. ⟨10.1016/j.tmaid.2020.101954⟩. ⟨hal-03211439⟩
11 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More